Crossject SA
PAR:ALCJ
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Crossject SA
Free Cash Flow
Crossject SA
Free Cash Flow Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Free Cash Flow | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Crossject SA
PAR:ALCJ
|
Free Cash Flow
-€9.4m
|
CAGR 3-Years
11%
|
CAGR 5-Years
1%
|
CAGR 10-Years
-2%
|
|
|
Guerbet SA
PAR:GBT
|
Free Cash Flow
€44.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-6%
|
CAGR 10-Years
3%
|
|
|
Affluent Medical SAS
PAR:AFME
|
Free Cash Flow
-€11.5m
|
CAGR 3-Years
3%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
|
Crossject SA
Glance View
Crossject SA manufactures and markets needle-free injection system. The company is headquartered in Dijon, Bourgogne-Franche-Comte. The firm specializes in needle-free, pre-filled, single-use injection systems for intradermal, subcutaneous and intramuscular applications for pharmaceutical companies. Is also has a pipeline and three drugs in the preclinical or clinical phase of research. The firm's products, which are based on well-known injectable drugs (chemicals and biologics), are designed to enhance patients' safety, compliance and comfort. Crossject’s first ZENEO SUPERGENERIC product is expected to reach the market in the year 2015. The firm has industrial partnerships with Hirtenberger and Recipharm.
See Also
What is Crossject SA's Free Cash Flow?
Free Cash Flow
-9.4m
EUR
Based on the financial report for Jun 30, 2025, Crossject SA's Free Cash Flow amounts to -9.4m EUR.
What is Crossject SA's Free Cash Flow growth rate?
Free Cash Flow CAGR 10Y
-2%
Over the last year, the Free Cash Flow growth was 35%. The average annual Free Cash Flow growth rates for Crossject SA have been 11% over the past three years , 1% over the past five years , and -2% over the past ten years .
